Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

CompletedOBSERVATIONAL
Enrollment

1,018

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Castration-resistant Prostate Cancer
Interventions
DRUG

enzalutamide

oral

Trial Locations (47)

Unknown

Numakunai

Aichi

Akita

Aomori

Chiba

Ehime

Fukui

Fukuoka

Fukushima

Gifu

Gunma

Hiroshima

Hokkaido

Hyōgo

Ibaraki

Ishikawa

Kagawa

Kagoshima

Kanagawa

Kochi

Kumamoto

Kyoto

Mie

Miyagi

Miyazaki

Nagano

Nagasaki

Nara

Niigata

Okayama

Okinawa

Osaka

Ōita

Saga

Saitama

Shiga

Shimane

Shizuoka

Tochigi

Tokushima

Tokyo

Tottori

Toyama

Wakayama

Yamagata

Yamaguchi

Yamanashi

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY